These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 11205312)
1. Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma. Kanavaros P; Stefanaki K; Vlachonikolis J; Papalazarou D; Rontogianni D; Arvanitis D; Antonakopoulos G; Gorgoulis V; Bai M; Agnantis NJ Anticancer Res; 2000; 20(6B):4619-25. PubMed ID: 11205312 [TBL] [Abstract][Full Text] [Related]
2. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas. Bai M; Vlachonikolis J; Agnantis NJ; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas. Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692 [TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct. Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677 [TBL] [Abstract][Full Text] [Related]
5. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue. Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886 [TBL] [Abstract][Full Text] [Related]
6. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Naka T; Toyota N; Kaneko T; Kaibara N Anticancer Res; 1998; 18(1B):555-64. PubMed ID: 9568177 [TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers. Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678 [TBL] [Abstract][Full Text] [Related]
8. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer. Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751 [TBL] [Abstract][Full Text] [Related]
9. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer. Tzai TS; Tsai YS; Chow NH Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007 [TBL] [Abstract][Full Text] [Related]
10. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations. Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961 [TBL] [Abstract][Full Text] [Related]
12. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma. Orjuela M; Orlow I; Dudas M; Ponce-CastaƱeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373 [TBL] [Abstract][Full Text] [Related]
13. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death. Kim LH; Peh SC; Poppema S Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421 [TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348 [TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
16. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome. Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours. Hara A; Saegusa M; Ichinoe M; Okayasu I J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus. Kanavaros P; Stefanaki K; Rontogianni D; Papalazarou D; Sgantzos M; Arvanitis D; Vamvouka C; Gorgoulis V; Siatitsas I; Agnantis NJ; Bai M Histol Histopathol; 2001 Oct; 16(4):1005-12. PubMed ID: 11642719 [TBL] [Abstract][Full Text] [Related]
19. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands. Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders. Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]